Mite Trial Failure 'The Final Straw' As Circassia Ends Anti-Allergy Investing

 
• By Sten Stovall

Circassia has thrown in the towel on investing in anti-allergy vaccines and will focus now on respiratory activities, after its house dust mite allergy study missed its primary endpoints.

Woman scratching neck
Circassia exits from allergies • Source: Shutterstock

More from Strategy

More from Business